Skip to main content
. 2024 Jul 18;7:27. doi: 10.20517/cdr.2024.42

Figure 3.

Figure 3

Relationship between genetic variants of pharmacologically relevant members of the SLC family 28, substrate drugs affected by changes in these proteins, and cancers treated with these compounds. SLC: Solute carrier.